A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...
A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...
Introduction: Dysregulated host cytokine responses to SARS-CoV-2 infection are a primary cause of progression to severe disease, whereas early neutralizing antibody responses are considered protective ...
Department of Mechanical and Mechatronics Engineering, University of Waterloo, 200 University Ave. W, Waterloo, ON N2L 3G1, Canada Waterloo Institute for Nanotechnology, University of Waterloo, 200 ...
Dr. Chan is a molecular biologist at the Broad Institute of M.I.T. and Harvard, and a co-author of “Viral: The Search for the Origin of Covid-19.” This article has been updated to reflect news ...
Singapore, Dec 9, 2021 - (ACN Newswire) - - Biolidics Limited ("Biolidics" or the "Company" and together with its subsidiaries, the "Group"), a medical technology company with a focus on innovative ...
1 Meizhou People's Hospital, Meizhou, China 2 Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population, Meizhou, China Background: The ...
Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already shipped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results